Unknown

Dataset Information

0

Effect of AKT3 expression on MYC- and caspase-8-dependent apoptosis caused by polo-like kinase inhibitors in HCT 116 cells.


ABSTRACT: Polo-like kinase (PLK) is a cell-cycle regulator that is overexpressed in several cancer cell types. Polo-like kinase is considered a novel target for cancer therapies, and several PLK inhibitors (PLKis), including BI 2536, BI 6727, and GSK461364, have been developed. In this study, we established five BI 2536-resistant cell lines from human colorectal cancer HCT 116 cells, to explore the resistance mechanism and identify predictable biomarkers of PLKis. We showed that PLKi-induced caspase-8 activation was attenuated in the BI 2536-resistant cell lines. We also showed that the expression of P-glycoprotein (P-GP) and AKT3 was upregulated, whereas that of MYC was downregulated in some BI 2536-resistant cell lines. Expression of P-GP conferred resistance to PLKis, and PLKi-induced apoptosis was dependent on MYC and caspase-8 in HCT 116 cells. We also showed for the first time that AKT3 suppressed BI 6727-induced caspase-8 activation and conferred resistance to PLKis. Collectively, these results indicate that MYC, caspase-8, P-GP, and AKT3 play critical roles in PLKi-induced apoptosis. Therefore, they are candidate biomarkers of the pharmacological efficacy of PLKis.

SUBMITTER: Nonomiya Y 

PROVIDER: S-EPMC5198950 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of AKT3 expression on MYC- and caspase-8-dependent apoptosis caused by polo-like kinase inhibitors in HCT 116 cells.

Nonomiya Yuma Y   Noguchi Kohji K   Tanaka Noritaka N   Kasagaki Takahiro T   Katayama Kazuhiro K   Sugimoto Yoshikazu Y  

Cancer science 20161219 12


Polo-like kinase (PLK) is a cell-cycle regulator that is overexpressed in several cancer cell types. Polo-like kinase is considered a novel target for cancer therapies, and several PLK inhibitors (PLKis), including BI 2536, BI 6727, and GSK461364, have been developed. In this study, we established five BI 2536-resistant cell lines from human colorectal cancer HCT 116 cells, to explore the resistance mechanism and identify predictable biomarkers of PLKis. We showed that PLKi-induced caspase-8 act  ...[more]

Similar Datasets

| S-EPMC6360298 | biostudies-literature
| S-EPMC9503335 | biostudies-literature
| S-EPMC7550984 | biostudies-literature
| S-EPMC10090242 | biostudies-literature
| S-EPMC10106425 | biostudies-literature
| S-EPMC5530076 | biostudies-other
| S-EPMC6651514 | biostudies-literature
| S-EPMC4763982 | biostudies-literature
| S-EPMC7561269 | biostudies-literature
| S-EPMC4611838 | biostudies-literature